We describe two cases of severe constrictive pericarditis arising after allogeneic BMT conditioning involving total body irradiation and melphalan to treat Philadelphia-chromosome positive ALL. Both patients required pericardectomy, resulting in marked improvement in ventricular filling. However, a degree of right-sided cardiac failure persisted in both patients secondary to restrictive cardiomyopathy. Constrictive pericarditis has not been previously described after BMT, but has been observed following thoracic radiotherapy for malignancy, usually involving a substantially higher radiation dose. Pericardial constriction and restrictive cardiomyopathy should be considered as causes of breathlessness and/or oedema occurring late after BMT. Bone Marrow Transplantation (2000) 25, 571-573. Keywords: Philadelphia-positive ALL; bone marrow transplantation; radiotherapy; constrictive pericarditis; restrictive cardiomyopathy
pneumonitis followed by grade III acute GVHD together with CMV infection in the early post-transplant period. Further infective complications included Pneumocystis carinii pneumonia and recurrent pyogenic sinusitis. At day 100 he remained in morphological and molecular CR.
He was readmitted with dyspnoea secondary to bilateral pleural effusions 281 days post-transplant, exhibiting signs of right-sided heart failure with a positive Kussmaul's sign (jugular venous pressure (JVP) elevated 10 cm). 12-lead ECG showed T-wave inversion in leads II, aVF and V [4] [5] [6] , with normal amplitude of QRS complexes. Chest X-ray confirmed pleural effusions but did not show any pericardial calcification or other abnormality. A lung ventilation/perfusion radioisotope scan was performed showing matched defects only. Pleural aspiration confirmed that the fluid was a transudate, and pleural cultures (including those for acid fast bacilli) remained negative. Transthoracic echocardiography (TTE) revealed normal left atrial, right atrial and right ventricular function with mild left-ventricular dysfunction and a small pericardial effusion; there was no pulmonary hypertension. CT of the thorax showed bilateral basal atelectasis initially, but on re-examination with an altered window, thickening of the pericardium to 4 mm was demonstrated. Ventricular dilatation was impaired and the diagnosis of constrictive pericarditis was made. A good initial clinical response to diuretics persisted for 9 months. However, on day 590 he was readmitted with worsening biventricular cardiac failure which responded poorly to bed rest and increase in diuretic dosage. On day 604 he underwent sternotomy and open total pericardectomy.
Pericardial histology revealed hyalinised fibrotic tissue with occasional chronic inflammatory cells. There was sclerosis of small blood vessels and appearances were in keeping with post-radiotherapy changes; no lymphoblasts were seen. Following this he made a reasonable recovery, complicated by peptic ulceration and mild cutaneous chronic GVHD. TTE at day 630 confirmed a small persistent pericardial effusion and mild right ventricular dysfunction but no persistent constriction. On day 740, he was readmitted in rapid atrial fibrillation and required DC cardioversion. Shortly thereafter he was readmitted in rightheart failure with JVP elevated 8 cm above the sternal angle; this decompensation coincided with an E. coli respiratory infection and improved after quinolone treatment. Repeat TTE revealed hypokinesis of both ventricles, while repeat CT thorax showed pleural fluid only and no pericardial constriction. A diagnosis of restrictive cardiomyopathy was made. Subsequently, with physiotherapy and cardiac rehabilitation, he has been stabilised on low dose diuretic therapy, and has returned to full-time employment. He remains in morphological and molecular remission from his ALL, over 1200 days post-BMT.
Case 2
A 39-year-old white male was diagnosed with Philadelphiapositive ALL, and treated with induction and consolidation chemotherapy as for case 1. Eight months after diagnosis he underwent an HLA-matched sibling BMT with melphalan (3 mg/kg) and TBI (12 Gy in six fractions at 25 cGy/min, twice daily for 3 days) conditioning. After an uncomplicated early post-transplant period he became thrombocytopenic due to late hypoplastic graft failure at day 559 and subsequently sustained two severe septicaemic episodes from gram-negative organisms (focus unknown) requiring inotropic support and ventilation. Following a course of prednisolone, the marrow cellularity improved and peripheral blood counts slowly normalised.
He was admitted 824 days post transplant with progressive dyspnoea, and was found to have signs of pericardial constriction: 20 mm of pulsus paradoxus and a steep descent to the y wave of his jugular venous pulse. TTE and CT of thorax confirmed pericardial thickening (4 mm) and constriction. Conservative management with diuretics was unsuccessful and he rapidly proceeded to open pericardectomy. Histological appearances of the resected pericardium were consistent with radiation-induced damage, with no features of graft-versus-host disease or recurrent ALL. Post-operatively there was a modest improvement in cardiac function allowing reduction in diuretic requirements. However, his respiratory function deteriorated 2 months post-pericardectomy, secondary to pulmonary damage subsequent to acute respiratory distress syndrome sustained during his previous episodes of septic shock. He died 985 days post BMT with a superadded E. coli chest infection. Permission for post-mortem examination was refused.
Discussion
The cardinal signs of pericardial constriction of raised JVP with prominent 'y' descent, pulsus paradoxus and Kussmaul's sign (inspiratory rise in JVP) are well recognised. 3 However, in only a small proportion of cases of pericardial disease is the aetiology clear; 4 also there is difficulty in clinical differentiation from restrictive cardiomyopathy, with which it may co-exist. 3 Late onset constrictive pericarditis is a well recognised complication of radiation of the thorax and mediastinum, and can present over two decades after radiation exposure. 5, 6 Usually this follows treatment for breast cancers or lymphomas (both Hodgkin's and non-Hodgkin's), involving doses of 30-50 Gy, with reported incidences between 2.5 and 20%. 7 The above two cases are the first to be described following BMT for which the conditioning radiation dose was substantially lower at 12 Gy. We have utilised this regimen in 96 allogeneic BMT patients together with melphalan or cyclophosphamide with no previous cases of cardiac damage apparent. Possibly synergistic effects of the co-administered melphalan or the previously administered chemotherapy played a role in the subsequent development of pericardial constriction. Coexisting myocardial restriction is frequently observed in those sustaining pericardial constriction due to irradiation, as in coronary artery and/or valvular disease. 7 Chemotherapeutic drugs have been linked to myocardial fibrosis in certain patients, 8 particularly alkylating agents. Adriamycin cardiotoxicity is increased when this is administered with radiotherapy, possibly by increases in free-radical generation. 9 It is plausible that concomitant chemo-and radio-therapy such as is given in transplant conditioning may synergise in the pathogenesis of myocardial and pericardial fibrosis. Alternatively the age and/or underlying diagnosis of these patients may have led to a greater liability to radiation-induced pericardial damage.
Pericardectomy is usually required in significant degrees of pericardial constriction 10 and prognosis from radiationinduced pericarditis has been reported as poor, particularly in those not treated by pericardectomy. 11 Others have questioned the value of pericardectomy for constrictive pericarditis, 12 although this may reflect case selection bias. Pericardial constriction should be borne in mind as an unusual cause of breathlessness and oedema in the medium to late post-BMT period. Pericardectomy is the treatment of choice for most patients, but consideration must be given to the possibility of concomitant myocardial, valvular or coronary arterial disease; appropriate cardiological assessment and investigation is important in determining management of this rare condition.
